Deal Spotlight
Jul 21, 2026July 21, 2026
3D Bio raises €46M in Series A with Expa
€46M
round size
series-a
stage
The Series A funding round closed on June 29, 2026, with Expa as the sole lead investor. This round marks the company's first institutional investment, bringing total capital raised to €460,000.
3D Bio operates as a software company based in the United States. It is categorized under Software & Developer Tools and is currently at the seed stage of development.
Related insights
- Cross-Country AnalysisSwitzerland shows higher single-round seed stall than UK by 5 percentage points
- Deal SpotlightPigment raises EUR223M in Series C+ with EQT Ventures, GS Growth and others participating
- Deal SpotlightDougs raises EUR50000000 Series A backed by Expedition Growth Capital
- Deal SpotlightWEG raises EUR44.8M Series B backed by BNDES
Explore the full dataset
Brouky tracks 37,000+ investors and 122,000+ investments across 134,000+ startups. Search by country, stage, and sector.